News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine, Division of Pulmonary and Critical Care. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Metformin, an inexpensive diabetes drug, has been found to reduce the risk of heart attacks and strokes triggered by air pollution by reducing inflammation in the lungs that triggers clotting.
Faculty, family and friends gathered at a symposium to honor Robert Goldman, PhD, chair of Cell and Molecular Biology, and his distinguished scientific career.
Students, faculty and alumni gathered for the seventh annual Driskill Day, celebrating the Driskill Graduate Program in Life Sciences by welcoming 28 new students and showcasing the program’s strengths in scholarship and scientific investigation.
A new study finds that excessive carbon dioxide in a patient’s bloodstream can lead to a restricted airway, calling into question current clinical practices for patients with chronic obstructive pulmonary disease.
Ali Shilatifard, PhD, has been appointed editor of Science Advances, an open-access journal published by the American Association for the Advancement of Science, which also publishes the journal Science.
- First Year Fellows Win 1st Place In Competition07.12.2018Congratulation to Taylor Poor and the rest of our 1st Year Clinical Fellows for winning a Procedure Championship at Midwest Bronchoscopy and Pleural Bootcamp with a Bronchoscopy Challenge. 17 institutions and 80 fellows overall participated in this event. (L to R) Laura Fry (U of Chicago), Ali Wolfe, Taylor Poor, Joe Deters, Ruben Mylvaganam, Christine Argento, and ChiChi Pickens.
- First Year Fellows Win 1st Place In Competition07.12.2018
Congratulation to Taylor Poor and the rest of our 1st Year Clinical Fellows for winning a Procedure Championship at Midwest Bronchoscopy and Pleural Bootcamp with a Bronchoscopy Challenge. 17 institutions and 80 fellows overall participated in this event. (L to R) Laura Fry (U of Chicago), Ali Wolfe, Taylor Poor, Joe Deters, Ruben Mylvaganam, Christine Argento, and ChiChi Pickens.
Treating mice with isradipine, a calcium channel blocker, prevented formation of toxic compounds that can cause Parkinson’s disease symptoms, according to a recent Northwestern Medicine study.
A team of scientists has uncovered the precise cells that flow into and harm the lung soon after a transplant. The study, published in The Journal of Clinical Investigation, may lead to drug therapies that target the destructive cells.
During spring break, the medical school welcomed undergraduate students for a pipeline program designed to nurture future medical students from underrepresented backgrounds.
A new study demonstrates how physicians can use genetic profiling of joint tissue to see which drugs will work for which patients.
The Northwestern Medical Orchestra, founded by two first-year medical students and open to all students, faculty, alumni and staff, recently began its inaugural season.
- Assembly on Allergy, Immunology and Inflammation hosts webinar featuring Northwestern Pulmonary researchers01.15.2018
A new Northwestern Medicine study suggests that a protein called Bim may be a novel therapeutic target for lupus.
Northwestern Medicine scientists identified a complex regulatory system that keeps cells functioning when their oxygen supply is cut off.
The 7th Annual Les Turner Symposium showcased the integration of ALS investigation and clinical care at Northwestern Medicine and the Les Turner ALS Foundation.
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
Northwestern Medicine scientists have published a paper in Nature Chemical Biology, detailing an innovative use of CRISPR-Cas9 technology that has helped reveal how oxidative stress explains a common herbicide’s link to risk of Parkinson’s.
A new study published in Academic Medicine reports early outcomes on student achievement, confidence and engagement after the medical school’s curriculum redesign.
Feinberg — and the University more broadly — is increasingly focused on ensuring that exciting discoveries made by basic scientists are also soon turned into treatments that impact human health.
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.
Northwestern Medicine scientists have demonstrated that an enzyme called IDH1 plays a significant role in cancer progression and may be a target for novel drug therapies.
Northwestern Medicine scientists have discovered that a unique population of immune cells play a key role in the development of pulmonary fibrosis, a fatal lung disease.
Northwestern Medicine scientists have discovered the mechanism that drives primary lung allograft dysfunction, the leading cause of death after lung transplantation.
Mitochondria have an important role in hematopoiesis, the body’s process for creating new blood cells, according to new Northwestern Medicine research.
Feinberg faculty members and fourth-year medical students were recognized for their achievements at the fifth annual Honors Day ceremony.
Computational Research Day brought together faculty members, investigators and students throughout Northwestern to showcase innovative research projects, share insights and tools, and strengthen the computational research community.
A new study defined the architecture of nuclear lamins, the fibrous proteins in a cell’s nucleus, providing further insights into their role in cell structure.
In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.